👨‍⚕️ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
📅 Reviewed: November 2026 • 🔍 Authority: DRAP / WHO ATC
📦 Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Inj 012835 1 Vialx.5 ml Rs.4500.00 Rs.5300.00
Inj 007971 1 Vialxl ml Rs.8191.00 Rs.9637.00

📋 Indications & Clinical Dosage

*Prophylaxis against hepatitis B infection for individuals exposed to the Hepatitis B virus:* BY IM INJ: Adult: 500 units, dose to be administered as soon as possible after exposure; ideally within 12-48 hours, but no later than 7 days after exposure. *Prevention of hepatitis B re-infection more than 6 months after liver transplantation in stable HBV-DNA negative patients:* BY SC INJ: Adult (body-weight up to 75 kg): 500 units once weekly, increased if necessary up to 1000 units once weekly;(body-weight 75 kg and above): 1000 units once weekly, dose to be started 2-3 weeks after last dose of intravenous hepatitis B immunoglobulin. *Prevention of hepatitis B in haemodialysed patients, Prophylaxis against re-infection of transplanted liver:* BY IV INF: Adult: (consult product literature). *Perinatal exposure of infants born to HbS Ag - positive mothers:* Neonate: 0.5 ml to infants within 12 hr after birth.

⚠️ Precautions & Warnings

Selective IgA deficiencies, anti-IgA antibodies, interference with live virus vaccines, risk factors for thrombotic events or acute renal failure. Monitor for adverse reactions and anaphylactoid reactions during infusion.

🔄 Drug Interactions

Hydantoins; e.g. Phenytoin, Virus vaccines, Live/measles, mumps, rubella vaccines, inactivated vaccines e.g. DPI, Hib, OPV, rabies vaccine, immunosuppressants.

⚠️ Adverse Reactions / Side Effects

Injection site reactions, abdominal pain, anaphylaxis, arthralgia, buccal ulceration, chest pain, dizziness, dyspnea, glossitis, headache, tremor Side-effects with IV use: abdominal distension, blood pressure fluctuations, deep vein thrombosis, haemolytic anaemia, injection site reactions, myocardial infarction, pulmonary embolism, stroke, thromboembolic events

📚 Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: HEPATITIS B IMMUNOGLOBULIN

HEPATECT CP
BIOTEST/NABIQASIM
Rs.9600.00
Rs.6000.00
HEPUMAN
HAKIMSONS
Rs.8694.40

More from POPULAR

GAMMARAAS
POPULAR
Rs.11730.00
GAMUNEX-C
POPULAR
Rs.23500.00
HYPERRAB
POPULAR
Rs.8900.00
HYPERRHO
POPULAR
Rs.3924.00

Same category: IMMUNE SERA AND IMMUNOGLOBULINS

ANTI RABIES SERUM
HOSPITAL SERVICES &...
View →
ASVS
AMSON
Rs.1764.00
BERIRAB-P
HAKIMSONS
Rs.5605.00
Rs.1544.40

⚡ Quick Actions

💬 Share via WhatsApp